Nearly one in four U.S. households reports using a GLP-1 medication, and projections suggest that figure could rise to 35 percent by 2030. However, new research shows many users may not be getting enough essential nutrients when taking these drugs, causing concerns about vitamin and mineral deficiencies as use grows.